These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 27742785)
21. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer. Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725 [TBL] [Abstract][Full Text] [Related]
22. Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study. Williamson SK; Lew D; Miller GJ; Balcerzak SP; Baker LH; Crawford ED Cancer; 2000 Mar; 88(5):1159-65. PubMed ID: 10699907 [TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. Else T; Williams AR; Sabolch A; Jolly S; Miller BS; Hammer GD J Clin Endocrinol Metab; 2014 Feb; 99(2):455-61. PubMed ID: 24302750 [TBL] [Abstract][Full Text] [Related]
26. Next-generation therapies for adrenocortical carcinoma. Altieri B; Ronchi CL; Kroiss M; Fassnacht M Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101434. PubMed ID: 32622829 [TBL] [Abstract][Full Text] [Related]
27. National Treatment Practice for Adrenocortical Carcinoma: Have They Changed and Have We Made Any Progress? Tierney JF; Chivukula SV; Poirier J; Pappas SG; Schadde E; Hertl M; Kebebew E; Keutgen X J Clin Endocrinol Metab; 2019 Dec; 104(12):5948-5956. PubMed ID: 31361313 [TBL] [Abstract][Full Text] [Related]
28. Pediatric adrenocortical carcinoma. Ilanchezhian M; Varghese DG; Glod JW; Reilly KM; Widemann BC; Pommier Y; Kaplan RN; Del Rivero J Front Endocrinol (Lausanne); 2022; 13():961650. PubMed ID: 36387865 [TBL] [Abstract][Full Text] [Related]
34. [Management of adrenocortical carcinomas in children]. Leblond P; Delebarre M; Aubert S Bull Cancer; 2011 May; 98(5):595-605. PubMed ID: 21596653 [TBL] [Abstract][Full Text] [Related]
35. [Three Cases of Advanced or Recurrent Adrenocortical Carcinoma Patients Treated with Etoposide, Doxorubicin and Cisplatin plus Mitotane]. Sasaki S Gan To Kagaku Ryoho; 2018 Jan; 45(1):67-70. PubMed ID: 29362311 [TBL] [Abstract][Full Text] [Related]
36. Adrenocortical carcinoma. van Ditzhuijsen CI; van de Weijer R; Haak HR Neth J Med; 2007 Feb; 65(2):55-60. PubMed ID: 17379929 [TBL] [Abstract][Full Text] [Related]
37. Clinical management of adrenocortical carcinoma. Fassnacht M; Allolio B Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):273-89. PubMed ID: 19500769 [TBL] [Abstract][Full Text] [Related]
38. [Diagnosis and treatment for adrenocortical carcinoma]. Iihara M; Obara T Gan To Kagaku Ryoho; 2004 Mar; 31(3):342-5. PubMed ID: 15045937 [TBL] [Abstract][Full Text] [Related]
39. A clinical study and treatment results of adrenocortical carcinoma patients presented in Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore. Khan MS; Ali A; Tariq I; Khan MA; Bakar MA; Anwar AW J Pak Med Assoc; 2019 May; 69(5):717-719. PubMed ID: 31105294 [TBL] [Abstract][Full Text] [Related]
40. Clinical management of malignant adrenal tumors. Kopf D; Goretzki PE; Lehnert H J Cancer Res Clin Oncol; 2001; 127(3):143-55. PubMed ID: 11260859 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]